Consensus AMETEK, Inc.

Equities

AME

US0311001004

Market Closed - Nyse 04:00:02 2024-03-28 pm EDT 5-day change 1st Jan Change
182.9 USD -0.45% Intraday chart for AMETEK, Inc. -1.09% +10.92%

Evolution of the average Target Price on AMETEK, Inc.

Price target over the last 5 years

History of analyst recommendation changes

bfd4e5bdccd45bb9f.8LKvK0gSXDO_j4W3h6d_O73gBZkA6rNSQydIexNkp1k.scrBTyZ7Nmrx_ub6xeMYeY6Tb-sxtdwAL24fHF8q1iy3-cZRFz8mfvei4g~6180b1e8c80c9af8bec9b89656982032
Ametek Insider Sold Shares Worth $1,277,456, According to a Recent SEC Filing MT
Ametek Inc/ Insider Sold Shares Worth $5,070,375, According to a Recent SEC Filing MT
Truist Securities Initiates AMETEK at Buy Rating With $210 Price Target MT
KeyBanc Raises AMETEK's Price Target to $205 From $182, Keeps Overweight Rating MT
RBC Trims Price Target on AMETEK to $188 From $192, Keeps Outperform Rating MT
North American Morning Briefing : Rate Doubts Keep -2- DJ
MORNING BID AMERICAS-Rates rebound cools, China commands rally RE
RBC Raises Price Target on AMETEK to $192 From $186, Keeps Outperform Rating MT
TD Cowen Downgrades AMETEK to Market Perform From Outperform, Adjusts Price Target to $160 From $165 MT
ANALYST RECOMMENDATIONS : Apple, AstraZeneca, Fedex, Shell, Uber... Our Logo
RBC Raises Price Target on AMETEK to $186 From $183, Cites 'Solid' Q3 Earnings Beat, 2023 Earnings Guidance Boost, Keeps Outperform Rating MT
RBC Lifts Price Target on AMETEK to $183 From $182, Keeps Outperform Rating MT
ANALYST RECOMMENDATIONS : Biogen, Booking, GSK, Papa John's, XPO... Our Logo
Seaport Global Initiates AMETEK With Buy Rating, $195 Price Target MT
Morgan Stanley Adjusts Price Target on AMETEK to $174 From $162, Maintains Overweight Rating MT
Mizuho Adjusts Price Target on AMETEK to $166 From $161, Maintains Buy Rating MT
KeyBanc Adjusts Price Target on AMETEK to $176 From $165, Maintains Overweight Rating MT
Wells Fargo Adjusts Price Target on AMETEK to $185 From $180, Maintains Overweight Rating MT
RBC Raises Price Target on AMETEK to $182 From $174 After 'Clean' Q2 Beat, Guidance Boost, Maintains Outperform Rating MT
AMETEK Q2 Adjusted Earnings, Sales Increase; Raises Guidance MT
RBC Raises Price Target on AMETEK to $174 From $165, Maintains Outperform Rating MT
Morgan Stanley Adjusts Price Target on AMETEK to $162 From $159, Maintains Overweight Rating MT
DA Davidson Adjusts Price Target on AMETEK to $180 From $177, Maintains Buy Rating MT
Morgan Stanley Adjusts AMETEK's Price Target to $159 From $155, Keeps Overweight Rating MT
Mizuho Adjusts Price Target on AMETEK to $161 From $153, Maintains Buy Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
182.9 USD
Average target price
188.3 USD
Spread / Average Target
+2.95%
High Price Target
210 USD
Spread / Highest target
+14.82%
Low Price Target
165 USD
Spread / Lowest Target
-9.79%

Consensus detail

Consensus revision (last 18 months)

Analysts covering AMETEK, Inc.

Truist Securities
KeyBanc Capital Markets
RBC Capital Markets
TD Cowen
Seaport Global Securities
Morgan Stanley
Wells Fargo Securities
Mizuho Securities
DA Davidson
Wolfe Research
BofA Securities
Loop Capital
Vertical Research
Berenberg Bank
Rosenblatt Securities
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings